CompletedNot Applicable

Pre-implantation Genetic Testing for Monogenic Disease: Single Center Experience

76 participantsStarted 2016-01-02

Plain-language summary

This monocentric retrospective observational study aims to evaluate the efficacy of pre-implantation genetic testing for monogenic diseases (PGT-M). The effectiveness will be assessed in terms of live birth rate (LBR), cumulative live birth rate (CLBR) per couple, and abortion rate (AR). Considering how many cycles the participants have undergone to achieve a viable blastocyst. The secondary objective is to evaluate the incidence of aneuploidy in unaffected embryos, in order to understand the need for pre-implantation genetic testing for aneuploidy (PGT-A)in addition to PGT-M.

Who can participate

Age range34 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients fertile or infertile that have undergone preimplantation genetic testing for monogenic diseases (PGTM). Exclusion Criteria: * No exclusion criteria will be taken into consideration.

What they're measuring

Live birth rate (LBR)

Timeframe: 7 years of inclusion

Cumulative live birth rate (CLBR) per couple

Timeframe: 7 years of inclusion

Abortion rate (AR)

Timeframe: 7 years of inclusion

Trial details

NCT IDNCT05936749

SponsorIstituto Clinico Humanitas

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-12

View on ClinicalTrials.gov More Genetic Disease trials